Europe Veterinary Antibiotics Market Growth, Trends and Future Scope 2034
Europe Veterinary Antibiotics Market Size- By Animal Type, By Drug Class, By Dosage Form - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Aug-2025 | Report ID: HLCA25258 | Pages: 1 - 259 | Formats*: |
| Category : Healthcare | |||
Europe Veterinary Antibiotics Market Introduction and Overview
According to SPER Market Research, the Europe Veterinary Antibiotics Market is estimated to reach USD 1.53 billion by 2034 with a CAGR of 2.57%.
The report includes an in-depth analysis of the Europe Veterinary Antibiotics Market, including market size and trends, product mix, Applications, and supplier analysis. The Europe Veterinary Antibiotics Market was valued at USD 1.19 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 2.57% between 2025 and 2034. The growing prevalence of livestock diseases, increased pet healthcare awareness, and rising zoonotic disease risks are driving demand for veterinary antibiotics in Europe. Germany, with the EU’s largest dairy cattle herd and numerous livestock-focused farms, presents strong market potential. Zoonotic diseases—transmissible from animals to humans—highlight the need for effective antibiotics to safeguard public health. As livestock farming and pet ownership rise, so does the urgency for disease prevention. The market is also shifting toward animal-only antibiotics and ionophores to address antibiotic resistance concerns. These targeted solutions help reduce cross-resistance risks, supporting both animal welfare and human health.
By Animal Type:
The cattle segment leads the market due to strong demand for beef and dairy products and the frequent occurrence of bacterial infections. Europe’s reputation for high-quality cattle products drives the need for strict health management to maintain herd productivity and quality. Veterinary antibiotics are essential in treating conditions such as mastitis, respiratory infections, and gastrointestinal diseases, which are common in cattle. These infections can severely impact animal health and farm economics. Effective antibiotic use helps prevent disease spread, ensuring sustained production and meeting both domestic and international market expectations.
By Drug Class:
The penicillins segment dominated the market in 2024, driven by its broad-spectrum effectiveness, proven safety, affordability, and regulatory support for responsible usage. Penicillin remains one of the most widely used antibiotic classes in veterinary medicine. Chemically, penicillins are categorized into monobactams and carbapenems, and by spectrum, they are classified as narrow, extended, or broad. Meanwhile, the sulfonamides segment is anticipated to witness notable growth in the coming years. As one of the oldest and most commonly used antibiotic classes in veterinary care, sulfonamides are favored for their affordability and broad effectiveness against a range of bacterial infections in livestock, poultry, and companion animals.
By Dosage Form:
In 2024, the oral solutions segment held the largest market share and is expected to grow significantly during the forecast period. Its dominance is attributed to ease of administration, cost-effectiveness, and high compliance, especially in large-scale livestock operations. Oral antibiotics can be easily mixed with drinking water or feed, minimizing stress compared to injections. This approach streamlines treatment, saving time and labor. Advanced formulation technologies and tools like automatic metering systems further enhance efficiency in treating large groups of animals simultaneously.
Regional Insights
In Germany, the veterinary antibiotics market is poised for growth, driven by increasing pet adoption, expanding animal husbandry, and heightened awareness of animal health. With about half of German farms specializing in livestock, the market environment is favorable. In the UK, growth is supported by rising pet ownership and insurance coverage, encouraging more veterinary visits. Organizations like the PDSA offer affordable treatments, addressing the growing number of injuries and illnesses in companion animals, thereby boosting demand for veterinary antibiotics and related drugs.
Market Competitive Landscape
The Europe Veterinary Antibiotics Market is moderately fragmented. Some key players are- Merck & Co., Inc., Ceva, Zoetis, Boehringer Ingelheim GmbH, Elanco, Vetoquinol S.A, Virbac, Calier, Bimeda, Inc., Prodivet Pharmaceuticals SA/NV.
Recent Developments:
In August 2024, RUMA CA&E announced its third annual Antibiotic Amnesty Month, set for November, to raise awareness of antimicrobial resistance (AMR) in European veterinary care. The campaign promotes the safe disposal of unused or expired antibiotics through pharmaceutical bins at clinics, aiming to reduce drug-resistant infections and environmental harm.
In February 2024, Blacksmith Medicines, Inc. partnered with Zoetis to develop new antibiotics for animal health, addressing rising antibiotic resistance affecting both animals and humans. Using Blacksmith’s metalloenzyme platform, the collaboration aims to create targeted treatments for serious livestock infections, reducing dependence on antibiotics also used in human medicine.
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Animal Type, By Drug Class, By Dosage Form |
| Regions covered | France, Germany, Italy, Spain, United Kingdom Rest of Europe |
| Companies Covered | Merck & Co., Inc., Ceva, Zoetis, Boehringer Ingelheim GmbH, Elanco, Vetoquinol S.A, Virbac, Calier, Bimeda, Inc., Prodivet Pharmaceuticals SA/NV. |
Key Topics Covered in the Report
- Europe Veterinary Antibiotics Market Size (FY’2021-FY’2034)
- Overview of Europe Veterinary Antibiotics Market
- Segmentation of Europe Veterinary Antibiotics Market By Animal Type (Pigs, Cattle, Sheep & Goats, Poultry, Others)
- Segmentation of Europe Veterinary Antibiotics Market By Drug Class (Tetracyclines, Penicillins, Sulfonamides, Macrolides, Trimethoprim, Lincosamides, Polymyxins, Aminoglycosides, Fluoroquinolones, Pleuromutilins, Other Drug Class)
- Segmentation of Europe Veterinary Antibiotics Market By Dosage Form (Oral Powder, Oral Solution, Injection, Other Dosage Forms)
- Statistical Snap of Europe Veterinary Antibiotics Market
- Expansion Analysis of Europe Veterinary Antibiotics Market
- Problems and Obstacles in Europe Veterinary Antibiotics Market
- Competitive Landscape in the Europe Veterinary Antibiotics Market
- Details on Current Investment in Europe Veterinary Antibiotics Market
- Competitive Analysis of Europe Veterinary Antibiotics Market
- Prominent Players in the Europe Veterinary Antibiotics Market
- SWOT Analysis of Europe Veterinary Antibiotics Market
- Europe Veterinary Antibiotics Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1.Introduction
1.1.Scope of the report1.2.Market segment analysis
2.Research Methodology
2.1.Research data source
2.1.1.Secondary Data2.1.2.Primary Data2.1.3.SPERs internal database2.1.4.Premium insight from KOLs
2.2.Market size estimation
2.2.1.Top-down and Bottom-up approach
2.3.Data triangulation
3.Executive Summary
4.Market Dynamics
4.1.Driver, Restraint, Opportunity and Challenges analysis
4.1.1.Drivers4.1.2.Restraints4.1.3.Opportunities4.1.4.Challenges
5.Market variable and outlook
5.1.SWOT Analysis
5.1.1.Strengths5.1.2.Weaknesses5.1.3.Opportunities5.1.4.Threats
5.2.PESTEL Analysis
5.2.1.Political Landscape5.2.2.Economic Landscape5.2.3.Social Landscape5.2.4.Technological Landscape5.2.5.Environmental Landscape5.2.6.Legal Landscape
5.3.PORTERs Five Forces5.3.1.Bargaining power of suppliers5.3.2.Bargaining power of buyers5.3.3.Threat of Substitute5.3.4.Threat of new entrant5.3.5.Competitive rivalry5.4.Heat Map Analysis
6.Competitive Landscape
6.1.Europe Veterinary Antibiotics Market Manufacturing Base Distribution, Sales Area, Product Type6.2.Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Europe Veterinary Antibiotics Market
7.Europe Veterinary Antibiotics Market, By Animal Type (USD Million) 2021-2034
7.1.Pigs7.2.Cattle7.3.Sheep & Goats7.4.Poultry7.5.Others
8.Europe Veterinary Antibiotics Market, By Drug Class (USD Million) 2021-2034
8.1.Tetracyclines8.2.Penicillins8.3.Sulfonamides8.4.Macrolides8.5.Trimethoprim8.6.Lincosamides8.7.Polymyxins8.8.Aminoglycosides8.9.Fluoroquinolones8.10.Pleuromutilins8.11.Other Drug Class
9.Europe Veterinary Antibiotics Market, By Dosage Form (USD Million) 2021-2034
9.1.Oral Powder9.2.Oral Solution9.3.Injection9.4.Other Dosage Forms
10.Europe Veterinary Antibiotics Market, (USD Million) 2021-2034
10.1.Europe Veterinary Antibiotics Market Size and Market Share
11.1.France
11.2.Germany
11.3.Italy
11.4.Spain
11.5.United Kingdom11.6.Rest of Europe
12.Company Profile
12.1.Merck & Co., Inc.
12.1.1.Company details12.1.2.Financial outlook12.1.3.Product summary12.1.4.Recent developments
12.2.Ceva
12.2.1.Company details12.2.2.Financial outlook12.2.3.Product summary12.2.4.Recent developments
12.3.Zoetis
12.3.1.Company details12.3.2.Financial outlook12.3.3.Product summary12.3.4.Recent developments
12.4.Boehringer Ingelheim GmbH
12.4.1.Company details12.4.2.Financial outlook12.4.3.Product summary12.4.4.Recent developments
12.5.Elanco
12.5.1.Company details12.5.2.Financial outlook12.5.3.Product summary12.5.4.Recent developments
12.6.Vetoquinol S.A
12.6.1.Company details12.6.2.Financial outlook12.6.3.Product summary12.6.4.Recent developments
12.7.Virbac
12.7.1.Company details12.7.2.Financial outlook12.7.3.Product summary12.7.4.Recent developments
12.8.Calier
12.8.1.Company details12.8.2.Financial outlook12.8.3.Product summary12.8.4.Recent developments
12.9.Bimeda, Inc.
12.9.1.Company details12.9.2.Financial outlook12.9.3.Product summary12.9.4.Recent developments
12.10.Prodivet Pharmaceuticals SA/NV
12.10.1.Company details12.10.2.Financial outlook12.10.3.Product summary12.10.4.Recent developments
12.11.Others
13.Conclusion
14.List of Abbreviations
15.Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Europe Veterinary Antibiotics Market is projected to reach USD 1.53 billion by 2034, growing at a CAGR of 2.57% during the forecast period.
Europe Veterinary Antibiotics Market size from 2025. The Market is expected to reach USD 1.53 billion by 2034, at a CAGR of 2.57% during the forecast period.
Europe Veterinary Antibiotics Market CAGR of 2.57% during the forecast period.
You can get the sample pages by clicking the link - Click Here
Europe Veterinary Antibiotics Market size is USD 1.53 billion from 2025 to 2034.
Europe Veterinary Antibiotics Market covered By Animal Type, By Drug Class, By Dosage Form
The North America is anticipated to have the highest Market share in the Europe Veterinary Antibiotics Market.
Merck & Co., Inc., Ceva, Zoetis, Boehringer Ingelheim GmbH, Elanco, Vetoquinol S.A, Virbac, Calier, Bimeda, Inc., Prodivet Pharmaceuticals SA/NV.
The report includes an in-depth analysis of the Europe Veterinary Antibiotics Market, including market size and trends, product mix, Applications, and supplier analysis.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
